Tresiba FlexTouch
Generic name: Insulin Degludec
Drug class:
Insulin
Usage of Tresiba FlexTouch
Tresiba is a long-acting insulin that starts to work several hours after injection and keeps working evenly for 24 hours. Insulin is a hormone that works by lowering levels of glucose (sugar) in the blood.
Tresiba is used to improve blood sugar control in adults with diabetes mellitus.
Tresiba may be used for type 1 or type 2 diabetes.
Tresiba is supplied in a multiple-dose vial or as a single-patient-use FlexTouch pen.
Tresiba FlexTouch is a disposable prefilled disposable pen available in two different strengths, U-100 (100 units/mL) containing 300 units of insulin and U-200 (200 units/mL) containing 600 units of insulin.
Tresiba FlexTouch side effects
Get emergency medical help if you have signs of an allergic reaction to Tresiba: hives, itching, skin rash; wheezing, tiredness, trouble breathing; feeling like you might pass out; nausea, diarrhea; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
Common Tresiba side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Tresiba FlexTouch
You should not use Tresiba if you are allergic to insulin degludec, or if you are having an episode of hypoglycemia (low blood sugar) or diabetic ketoacidosis (call your doctor for treatment).
Tresiba should not be given to a child younger than 1 year old.
Tell your doctor if you are pregnant or breastfeeding.
Follow your doctor's instructions about using Tresibaif you are pregnant or you become pregnant. Controlling diabetes is very important during pregnancy, and having high blood sugar may cause complications in both the mother and the baby.
Relate drugs
- Admelog
- Afrezza
- Apidra
- Myxredlin
- Basaglar
- Basaglar KwikPen
- Basaglar Tempo Pen
- Exubera
- Fiasp
- Humalog
- Humalog Mix
- Humalog Mix 50/50
- Humalog Mix 50/50 KwikPen
- Humalog Mix 75/25
- Humalog Mix 75/25 KwikPen
- HumuLIN 50/50
- Humulin 70/30
- HumuLIN 70/30 KwikPen
- Humulin N
- HumuLIN N KwikPen
- Humulin R
- Humulin R (Concentrated) U-500
- HumuLIN R KwikPen (Concentrated) U-500
- Insulin Aspart
- Insulin aspart and insulin aspart protamine
- Insulin aspart and insulin degludec
- Insulin aspart protamine and insulin aspart
- Insulin aspart, recombinant
- Insulin degludec
- Insulin Detemir
- Insulin glargine
- Insulin Glargine Prefilled Pen
- Insulin Glargine Solostar Pen
- Insulin glargine, recombinant
- Insulin glargine-aglr, recombinant
- Insulin glargine-yfgn, recombinant
- Insulin glulisine
- Insulin human inhaled
- Insulin human isophane (nph)
- Insulin human regular
- Insulin inhalation
- Insulin isophane
- Insulin isophane and insulin regular
- Insulin Lispro
- Insulin lispro and insulin lispro protamine
- Insulin lispro protamine and insulin lispro
- Insulin lispro-aabc
- Insulin nph and regular
- Insulin Regular
- Insulin regular, concentrated U-500
- Lantus
- Lantus SoloStar
- Lantus Solostar Pen
- Levemir
- Levemir Flexpen
- Levemir FlexTouch
- Lispro-PFC
- Lyumjev
- Lyumjev Kwikpen (Insulin lispro Intravenous, Subcutaneous)
- Lyumjev Kwikpen (Insulin lispro-aabc Intravenous, Subcutaneous)
- Novolin 70/30
- Novolin N
- Novolin R
- NovoLog
- NovoLog FlexPen
- NovoLog Mix 70/30
- NovoLog Mix 70/30 FlexPen
- NovoLog PenFill
- ReliOn/Novolin 70/30
- ReliOn/NovoLIN N
- Rezvoglar KwikPen (Insulin glargine, recombinant Subcutaneous)
- Rezvoglar KwikPen (Insulin glargine-aglr, recombinant Subcutaneous)
- Ryzodeg 70/30
- Semglee
- Semglee (Insulin glargine, recombinant Subcutaneous)
- Semglee (Insulin glargine-yfgn, recombinant Subcutaneous)
- Semglee (Prefilled Pen)
- Semglee (Vial)
- Semglee Pen (Insulin glargine, recombinant Subcutaneous)
- Semglee Pen (Insulin glargine-yfgn, recombinant Subcutaneous)
- Toujeo
- Toujeo Max SoloStar
- Tresiba FlexTouch
How to use Tresiba FlexTouch
Usual Adult Dose of Tresiba for Diabetes Type 1:
Dose should be individualized based on clinical response; this basal insulin should be used in regimens with short or rapid-acting insulin Insulin-naive patients: Initial dose: One-third to one-half the total daily insulin requirement suBCutaneously once a day. -The initial total daily insulin requirement in insulin naive patients is generally 0.2 to 0.4 units of insulin per kilogram of body weight. Current insulin users: Initiate at the same total daily dose of current long or intermediate-acting insulin subcutaneously once a day. Comments: -Adjust dosage according to metabolic needs, blood glucose measurements, and glycemic goals; dose increases should occur no sooner than every 3 to 4 days. -When changing treatment regimens, the dose and frequency of short-acting insulin may need to be adjusted. -To minimize hypoglycemia, closely monitor blood glucose, especially with changing regimens.
Usual Adult Dose of Tresiba for Diabetes Type 2:
Initial dose: 10 units subcutaneously once a day Current insulin users: Initiate at the same total daily dose of current long or intermediate-acting insulin subcutaneously once a day. Comments: -Adjust dosage according to metabolic needs, blood glucose measurements, and glycemic goals; dose increases should occur no sooner than every 3 to 4 days. -When changing treatment regimens, the dose and frequency of short-acting insulin or other anti-diabetic medications may need to be adjusted. -To minimize hypoglycemia, closely monitor blood glucose, especially with changing regimens.
Warnings
You should not use Tresiba if you are having an episode of hypoglycemia (low blood sugar).
Never share a Tresiba injection pen with another person, even if the needle has been changed.
What other drugs will affect Tresiba FlexTouch
Tell your doctor if you also take pioglitazone or rosiglitazone (sometimes contained in combinations with glimepiride or metformin). Taking certain oral diabetes medicines while you are using insulin may increase your risk of serious heart problems.
Tresiba may not work as well when you use other medicines at the same time. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed here. Tell your doctor about all medicines you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions